CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC

EIN: 043503931 501(c)(3) Health Care

AUSTIN, TX

Total Revenue
$9,205,905
Total Expenses
$9,491,939
Total Assets
$3,169,764
Net Assets
$1,392,608
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2000
Legal Domicile
MA
Principal Officer
CHRIS DECKER
Phone
5123635826
Tax Period
2024-01-01 to 2024-12-31

CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC, founded in 2000, is a community nonprofit in the Health Care sector that reported $9.2M in total revenue in fiscal year 2024.

Mission

TO CREATE CONNECTED STANDARDS ACROSS THE STUDY INFORMATION LIFECYCLE TO ENABLE ACCESSIBLE, INTEROPERABLE, AND REUABLE DATA FOR MORE MEANINGFUL AND EFFECTIVE RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $4,726,329 Revenue: $132,186

IN 2024, CDISC INTRODUCED A STRATEGIC ROADMAP TO EXPAND AND ENABLE STANDARDS DRIVEN AUTOMATION ACROSS THE END-TO-END STUDY INFORMATION LIFECYCLE FROM STUDY DESIGN THROUGH RESULTS. CDISC IS MOBILIZING...

Read more

IN 2024, CDISC INTRODUCED A STRATEGIC ROADMAP TO EXPAND AND ENABLE STANDARDS DRIVEN AUTOMATION ACROSS THE END-TO-END STUDY INFORMATION LIFECYCLE FROM STUDY DESIGN THROUGH RESULTS. CDISC IS MOBILIZING ITS WORK AROUND THREE KEY PILLARS: EXPAND & CONNECT, ENABLE & AUTOMATE, AND ENGAGE & ADOPT POSITIONING CDISC AND THE INDUSTRY FOR FUTURE INNOVATION AND TRANSFORMATION. EXPAND & CONNECT: WE AIM TO EMBRACE AND ADOPT DIGITAL STUDY DESIGN, CREATING CONNECTED STANDARDS ACROSS THE CLINICAL RESEARCH INFORMATION LIFECYCLE WHILE DEFINING A CLEAR PIPELINE FOR INTEGRATING NEW DATA SOURCES. ENABLE & AUTOMATE: WE WILL DEVELOP READY-TO-USE IMPLEMENTATION STANDARDS THAT ARE ENABLED THROUGH TECHNOLOGY, REDUCE VARIABILITY AND FOCUSED ON INTEROPERABILITY AND AUTOMATION TO LOWER THE BARRIER TO STANDARDS USE, AND INCREASING COMMUNICATION TO BETTER ENABLE OUR STAKEHOLDERS.THROUGHOUT 2024, CDISC CONTINUES TO UPDATE NEW VERSIONS OF THE CDISC FOUNDATIONAL AND THERAPEUTIC AREA STANDARDS (SEND, SDTM, SDTMIG, ADAM, CONTROLLED TERMINOLOGY, AND TMF) AS WELL AS HOSTING WORKSHOPS AND HACKATHONS TO FURTHER DEVELOP STANDARDS AND TOOLS TO DRIVE INNOVATION. 2024 TECHNICAL MILESTONES: -INTRODUCED THE ANALYSIS RESULTS STANDARD (ARS) V1.0 TO TACKLE THE INEFFICIENCIES IN GENERATING MACHINE-READABLE ANALYSIS RESULTS. ARS ENABLES AUTOMATION, REPRODUCIBILITY, TRACEABILITY, AND REUSABILITY, TRANSFORMING HOW ANALYSIS RESULTS ARE DESCRIBED, ORGANIZED, AND APPLIED.-LAUNCHED A NEW BIOMEDICAL CONCEPTS (BC) BROWSER TO SIMPLIFY ACCESS TO THE LATEST BCS AND SDTM DATASET SPECIALIZATIONS. THE BROWSER FEATURES SEARCH AND FILTER TOOLS, USER-FRIENDLY VIDEO GUIDES, AND OPTIONS TO DOWNLOAD FILES VIA EXCEL OR RETRIEVE DATA THROUGH CDISC LIBRARY APIS.-RELEASED THE OBSERVATIONAL STUDIES GUIDE V1 TO PROVIDE STRATEGIES FOR USING SDTM WITH OBSERVATIONAL STUDIES AND REAL-WORLD DATA. DEVELOPED COLLABORATIVELY WITH THE DRAGON CONSORTIUM, CJUG, AND GLOBAL INDUSTRY EXPERTS, THE GUIDE HELPS INVESTIGATORS REPRESENT DATA CONCEPTS IN A CDISC-REVIEWED APPROACH.-LAUNCHED THE ETFL PORTAL IN PARTNERSHIP WITH CLYMB CLINICAL PROVIDING READY-TO-USE, ARS-COMPLIANT PACKAGES TO STREAMLINE TFL GENERATION. EACH PACKAGE INCLUDES DISPLAY SHELLS, ADAM DATASETS AND METADATA, ANALYSIS RESULTS METADATA, AND ANALYSIS OUTPUTS, PROMOTING THE ADOPTION OF ARS ACROSS THE INDUSTRY.-INTRODUCED VERSION 2.1 OF STUDY DATA TABULATION MODEL (SDTM) WHICH INCLUDES NEW DATASET AND VARIABLE STANDARDS TO MEET THE NEED FOR DOMAIN MODELS DESCRIBED IN THE TOBACCO IMPLEMENTATION GUIDE VERSION 1.0 (TIG V1.0).-IN COLLABORATION WITH FDA CTP, LAUNCHED FOUNDATIONAL STANDARD FOR COLLECTING, ANALYZING, AND EXCHANGING TOBACCO PRODUCT DATA. THE TIG STANDARDIZES SUBMISSIONS USING CDASH, SDTM, AND ADAM MODELS TO SUPPORT RESEARCH, REVIEW, AND HARM REDUCTION EFFORTS.-INTRODUCED AN OPEN-SOURCE R PACKAGE DESIGNED TO FACILITATE THE CREATION OF STUDY DATA TABULATION MODEL (SDTM) DATASETS. DEVELOPED THROUGH A COLLABORATION AMONG PHARMACEUTICAL COMPANIES AND SPONSORED BY THE CDISC OPEN SOURCE ALLIANCE (COSA), {SDTM.OAK} OFFERS A MODULAR FRAMEWORK WITH REUSABLE ALGORITHMS TO AUTOMATE SDTM DATASET CREATION.-EXPANDED PROTOCOL DIGITALIZATION WITH FULL PROTOCOL COVERAGE IN THE USDM 3 MODEL, ENHANCING DOWNSTREAM CONNECTIVITY, ALIGNING WITH ICH M11, AND EXPLORING THE USE OF THE CDISC OPEN RULE ENGINE FOR USDM CONFORMANCE CHECKS.-INTRODUCED THE ECRF PORTAL, OFFERING READY-TO-USE, CDASH-COMPLIANT ANNOTATED ECRFS IN PDF, HTML, AND XML FORMATS. THESE ECRFS CAN BE USED AS-IS OR IMPORTED INTO EDC SYSTEMS FOR CUSTOMIZATION, PROVIDING FLEXIBLE EXAMPLES FOR DATA COLLECTION.-DEFINE-XML V2.1.7 PACKAGE UPDATED REFLECTING THE RELEASE OF CONTROLLED TERMINOLOGY PACKAGE 58.

Program 2
Expenses: $799,801 Revenue: $1,018,411

EDUCATION - IN 2024 CDISC EDUCATION TRAINED 940 INDIVIDUALS WITH OVER 100 INSTRUCTOR-LED TRAININGS, 30 HOURS OF NEW MATERIALS, IN 20 COUNTRIES WITH 2 NEW TRANSLATIONS. WE DEVELOPED NEW HANDS-ON...

Read more

EDUCATION - IN 2024 CDISC EDUCATION TRAINED 940 INDIVIDUALS WITH OVER 100 INSTRUCTOR-LED TRAININGS, 30 HOURS OF NEW MATERIALS, IN 20 COUNTRIES WITH 2 NEW TRANSLATIONS. WE DEVELOPED NEW HANDS-ON TRAININGS FOR ARS IMPLEMENTATION, CDISC OPEN RULES IMPLEMENTATION, DATASET-JSON IMPLEMENTATION, ADAM ADVANCED IMPLEMENTATION, AND SDTM ADVANCED IMPLEMENTATION. WE DEVELOPED AND OFFERED NEW VIRTUAL TRAININGS INCLUDING NORD RARE DISEASES, TAUG SDTM MEDICAL DEVICES, TOBACCO IMPLEMENTATION GUIDE V1, AND TMF EXCELLENCE AND A NEW ON-DEMAND COURSE "INTRO TO TMF."

Program 3
Expenses: $1,014,489 Revenue: $1,304,724

EVENTS - CDISC HELD 7 GLOBAL EVENTS (UNITED STATES, GERMANY, JAPAN, CHINA, KOREA) ACROSS THREE CONTINENTS WITH MORE THAN 1,200 ATTENDEES GATHERING TO NETWORK, SHARE THEIR EXPERTISE, BEST PRACTICES...

Read more

EVENTS - CDISC HELD 7 GLOBAL EVENTS (UNITED STATES, GERMANY, JAPAN, CHINA, KOREA) ACROSS THREE CONTINENTS WITH MORE THAN 1,200 ATTENDEES GATHERING TO NETWORK, SHARE THEIR EXPERTISE, BEST PRACTICES, AND LESSONS LEARNED ABOUT LEVERAGING CDISC STANDARDS TO BRING EFFICIENCIES AND CLARITY TO DATA. 2024 BROUGHT TOGETHER PROFESSIONALS FROM A WIDE RANGE OF ROLES, INCLUDING MANAGERS, DIRECTORS, OPERATIONS EXPERTS, AND EXECUTIVES. ATTENDEES ARE FROM PHARMACEUTICAL, BIOTECH, CRO, TECHNOLOGY, AND ACADEMIC SECTORS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $4,558,549
Program Service Revenue $4,608,298
Investment Income $39,058
Other Revenue $0
TOTAL REVENUE $9,205,905

Expense Breakdown

Grants Paid $0
Salaries & Benefits $5,470,645
Fundraising Expenses $654,714
Program Expenses $6,948,099
Other Expenses $4,021,294
TOTAL EXPENSES $9,491,939

Year-over-Year Comparison

2024 2023 Change
Revenue $9,205,905 $9,333,128 0.0%
Expenses $9,491,939 $11,224,779 -0.2%
Net Income $-286,034 $-1,891,651 -0.8%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
14
Independent Members
14
Employees
40
Volunteers
14

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$1,100,728
Total Directors
14
$0
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ERIK PULKSTENIS CHAIR 3.00
Officer Director
$0 $0 $0
BROOKE HINKSON CHAIR-ELECT 2.00
Officer Director
$0 $0 $0
PAM HOWARD PAST-CHAIR 2.00
Officer Director
$0 $0 $0
CHRISTINA REITH DIRECTOR 2.00
Director
$0 $0 $0
MIHOKO OKADA DIRECTOR 2.00
Director
$0 $0 $0
WENJUN BAO DIRECTOR 2.00
Director
$0 $0 $0
JONATHAN CHAINEY DIRECTOR 2.00
Director
$0 $0 $0
KAREN CURRAN DIRECTOR 2.00
Director
$0 $0 $0
DAVID HARDISON DIRECTOR 2.00
Director
$0 $0 $0
PANDU KULKARNI DIRECTOR 2.00
Director
$0 $0 $0
DOMINIC LABRIOLA DIRECTOR 2.00
Director
$0 $0 $0
LISA LIN DIRECTOR 2.00
Director
$0 $0 $0
HIROSHI MASUMOTO DIRECTOR 2.00
Director
$0 $0 $0
RHONA O'DONNELL DIRECTOR 2.00
Director
$0 $0 $0
DAVID E EVANS FORMER PRESIDENT & CEO 40.00
Officer
$220,202 $29,981 $250,183
CHRIS DECKER PRESIDENT & CEO (AS OF 1/1/24) 40.00
Officer
$324,220 $47,487 $371,707
RHONDA FACILE VP, DEV. & PARTNERS (UNTIL 9/26/24) 40.00
Officer
$188,836 $29,705 $218,541
SHEILA LEAMAN VP GLOBAL RELATIONS (UNTIL 12/31/24) 40.00
Officer
$220,273 $40,024 $260,297
ANTHONY CHOW EXECUTIVE DIR., STRATEGY & INNOVATION 40.00
Highest
$177,915 $12,386 $190,301
CHARLES SHADLE HEAD OF DATA SCIENCE OPERATIONS 40.00
Highest
$200,052 $13,579 $213,631
PETER VAN REUSEL CHIEF STANDARDS OFFICER 40.00
Highest
$287,695 $0 $287,695
BESS LEROY NIETO HEAD OF STANDARDS DEVELOPMENT 40.00
Highest
$173,665 $31,217 $204,882
CHRISTINE CONNOLLY HEAD OF STANDARDS PROJECTS 40.00
Highest
$181,045 $11,960 $193,005
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $9,205,905 $9,491,939 $3,169,764 $-286,034
2023 $9,333,128 $11,224,779 $3,979,569 $-1,891,651
2022 $8,105,543 $9,610,015 $5,085,701 $-1,504,472
2021 $7,747,958 $7,940,015 $6,322,350 $-192,057
2020 $6,961,045 $7,619,332 $6,518,601 $-658,287
2019 $10,389,051 $9,026,845 $7,185,485 $1,362,206
2018 $9,038,450 $7,627,347 $5,398,784 $1,411,103
Explore More Nonprofits
Top 100 Nonprofits in Texas Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC with other nonprofits in Texas and across the country.